Introduction
Gluten is a group of proteins which is found within several cereals, including wheat, rye and barley. Wheat gluten is composed of gliadins and glutenins, two major storage proteins (prolamins) found in the endosperm, representing up to 85% of the total protein content. 1 Wheat gluten is extensively utilised in the bakery industry as it confers cohesiveness, viscoelastic and gas retention properties to dough. 2 The viscous properties of wheat gluten have been attributed to gliadins while the elastic properties arise from the glutenins. 3 Wheat is a major protein source in the human diet. It is estimated to contribute up to 30% of dietary protein intake. 2 However, people suffering from coeliac disease have been recommended to follow a strict gluten free-diet. 2 Enzymatic hydrolysis of wheat gluten has been proposed to reduce its allergenic potential. [4] [5] [6] Interestingly, the process of hydrolysis itself may lead to the release of biologically active peptides.
In silico analysis of wheat gluten proteins has revealed that they contain several known bioactive peptides having potential antioxidant, antihypertensive and antidiabetic properties. 7 The bioactive properties of wheat gluten hydrolysates such as their antioxidant and antihypertensive properties have been demonstrated in vitro. [8] [9] [10] Numerous dipeptidyl peptidase IV (DPP-IV) inhibitory peptides have been identified within wheat gliadins and glutenins during in silico studies. 11, 12 DPP-IV is a metabolic enzyme which can bring about the degradation and inactivation of incretins (e.g., glucagon like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP)). Incretins have an insulinotropic action during the post prandial phase, generally resulting in enhanced serum glucose regulation. Inhibition of DPP-IV may lead to the restoration of incretin insulinotropic action particularly in people suffering from type 2 diabetes (T2D). 13 Therefore, DPP-IV inhibition is therapeutically targeted as a means to achieving better serum glucose regulation in T2D sufferers. Several dietary peptides inhibit DPP-IV in vitro and also in vivo, in small animals, for reviews see: 14, 15 . Velarde-Salcedo et al. 16 showed that an in vitro gastrointestinal digest of wheat flour was able to inhibit DPP-IV. To date, limited information is available in the literature in relation to the role of wheat gluten hydrolysates on DPP-IV inhibition. Wheat gluten contains relatively high levels of Pro, Asn, Gln and Arg, but low levels of essential amino acids such as Trp, Lys and Met. 1 Pro residues have frequently been reported in peptides having DPP-IV inhibitory properties. In particular, peptides with a Pro at the penultimate position, which are preferred DPP-IV substrates, display substrate-type inhibition of DPP-IV.
Therefore, the utilisation of protein substrates rich in Pro, such as wheat gluten, appears to be of interest for the generation of DPP-IV inhibitory peptides. The aim of this study was to investigate the generation of DPP-IV inhibitory peptides during enzymatic hydrolysis of wheat gluten. This was achieved by hydrolysing wheat gluten with Debitrase HWY20, a commercial food-grade enzyme preparation. The physicochemical characteristics (degree of hydrolysis (DH), peptide profile and molecular mass distribution) of the gluten hydrolysates were assessed. The stability of the DPP-IV inhibitory properties of the gluten hydrolysates following incubation with digestive enzymes was studied using an in vitro simulated gastrointestinal digestion (SGID) protocol. Peptide identification was subsequently carried out by liquid chromatography-tandem mass spectrometry (LC-MS/MS). ), a porcine pancreatic enzyme preparation, was supplied by AB Enzymes (Darmstadt, Germany).
Materials and Methods

Reagents
Enzymatic hydrolysis of gluten
The protein content of gluten was determined in triplicate (n=3) using the BCA assay as already outlined earlier. 21 Gluten was hydrolysed with Debitrase HYW20, using a 2 factor  3 level design of experiments (DOE). Each factor was centred and reduced (z-centred values). Preliminary experiments showed that hydrolysis times < 6 h were not sufficient to fully hydrolyse gluten with Debitrase HYW20. In addition, pH (6.0-8.0) and substrate concentration (2-10% (w/w)) alterations were studied. Gluten aggregation occurred at pH > 6.0 and concentrations > 2% (w/w). These preliminary experiments showed that it was not practical to adjust the pH of the gluten suspension to the optimal pH for Debitrase HYW20 (pH 7.0) or to study substrate concentrations > 2% (w/w) and hydrolysis times < 6 h. Therefore, two hydrolysis factors, i.e., incubation temperature (T) and enzyme: substrate ratio (E:S), which did not cause gluten to precipitate or induce insufficient gluten hydrolysis, were selected. These factors were studied at three levels (T, 40(-1), 50(0) and 60(+1)°C and E:S, 0.5(-1), 1(0) and 1.5(+1)% (w/w)) ( Table 1) . These levels were chosen to set the central point conditions of the DOE (i.e., T 50C and E:S 1%(w/w)) as described previously for the hydrolysis of bovine whey proteins with Debitrase HYW20. 22 Nine different hydrolysates (H1-H9) were generated once with the exception of the hydrolysate at the central point conditions generated in triplicate (H2, H2B, H2C, n=3). Gluten was suspended (2.0% (w protein equivalent/w)) in distilled water for 60 min in a water bath (Lauda E100, Lauda Brinkmann, Lauda-Königshofen, Germany) set at the hydrolysis temperature as defined by the DOE. The pH of the gluten suspension was pH 5.6. Debitrase HYW20 was subsequently added at the desired E:S ratio as defined in the DOE. Hydrolysis was conducted for 24 h 23 and the enzyme was subsequently heat inactivated in a water bath set at 90°C for 20 min. The negative control corresponded to unhydrolysed gluten which was incubated using the same temperature and time conditions as the hydrolysate but without enzyme addition. Samples were freeze-dried (FreeZone 18L, Labconco, Kansas City, MO, USA) and stored at -20°C prior to analysis.
In vitro simulated gastrointestinal digestion (SGID) of intact and hydrolysed gluten
Intact gluten and H9 were subjected to SGID in vitro as described earlier. 24 Briefly, samples were resuspended in distilled water to 2% (w protein equivalent /w) for 30 min at 37C and the pH was adjusted to 2.0 using 1 N HCl. Hydrolysis with pepsin (E:S 2.5% (w/w)) was carried out under pH regulation (2.0) with HCl (pH stat Titrando 843, Tiamo 1.4 Metrohm, Dublin, Ireland) for 90 min at 37°C. Pepsin was then heat inactivated (90°C, 20 min). An aliquot of the peptic hydrolysate (H9_pepsin or Gluten_pepsin) was brought to pH 7.5 using 1 M NaOH and was subsequently hydrolysed with Corolase PP (E:S 1% (w/w)) for 150 min at 37°C, pH 7.5 using a pH stat (Metrohm), yielding H9_CorPP or Gluten_CorPP. Corolase PP contains several intestinal enzyme activities, including trypsin, chymotrypsin, elastase and various exopeptidases. 25 The reaction was terminated by thermal treatment (90°C, 20 min). Samples were freeze-dried and stored at -20°C until utilisation.
Degree of hydrolysis (DH)
The DH of the hydrolysates (H1-H9) was determined in triplicate (n=3) using the TNBS method as already outlined. 26 Absorbance values at 350 nm were measured with a microplate reader (Biotek Synergy HT, Winoosky, VT, USA). The free amino group concentration (AN) was calculated using a Leu standard curve and the absorbance values. 27 The DH was calculated according to Equation 1:
With AN 1 , the free amino group content of the negative control, i.e., unhydrolysed protein (mg gPlease do not adjust margins
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and Npb, the amino group content of the peptide bonds in the protein substrate (112.1 mg g -1 protein for wheat gluten) 28 .
Molecular mass distribution profiling of the hydrolysates using gel permeation high performance liquid chromatography (GP-HPLC)
Gluten hydrolysates were analysed by GP-HPLC as described earlier. 29 A Waters HPLC system (model 600 binary pump, model 2707 autosampler and model 2489 dual λ absorbance detector interfaced with Empower™, Milford, MA, USA) was used for this purpose. Samples were resuspended in the mobile phase (0.1% (v/v) TFA and 30% HPLC grade ACN in HPLC water) at 0.21% (w protein equivalent/v) and filtered through 0.2 µm PTFE syringe filters (VWR). Separation was carried out in isocratic mode at 21°C by injecting 20 µL of sample into a TSK G2000 SW separating column (600×7.5 mm ID -Tosoh Bioscience, Tokyo, Japan) connected to a TSKGEL SW guard column (75×7.5 mm ID -Tosoh Bioscience). The flow rate was set at 0.5 mL min -1 for 60 min. The absorbance was monitored at 214 nm. Molecular mass standards (i.e., BSA, β-Lg, -La, aprotinin, bacitracin, Leu-Trp-Met-Arg and Asp-Glu) were used to calibrate the method ( Supplementary Fig. S1 ). Four molecular mass bands within the resulting chromatogram were defined as > 10, 10-5, 5-1 and < 1 kDa.
Peptide profiling of the hydrolysates using reverse-phase ultraperformance liquid chromatography (RP-UPLC)
The peptide profile of the gluten hydrolysates was determined by RP-UPLC (Acquity, Waters) as described earlier. 30 Solvent A was 0.1% (v/v) TFA in MS grade water and solvent B was 0.1%
(v/v) TFA and 80% MS grade ACN in water. The samples were resuspended (0.43% w protein equivalent/v) in solvent A and filtered with 0.2 µm cellulose acetate filters (VWR). Separation was carried out at 30°C at a flow rate of 0.3 mL min -1 using an injection volume of 10 µL. An Acquity UPLC BEH C18, 130 Å column (2.1 mm  50 mm  1.7 µm) equipped with an Acquity BEH C18 (1.7 µm) vanguard pre-column (Waters) were used. Peptides and proteins were eluted using a linear gradient: 0-0.28 min: 100% A; 0.28-60 min: 100-40% A. Absorbance was monitored at 214 nm.
Dipeptidyl peptidase IV (DPP-IV) inhibition assay
The freeze-dried samples were dispersed in HPLC grade water at concentrations ranging from 1.9 × 10 -2 to 1.9 mg mL -1 (final concentration expressed in mg protein equivalent mL -1 ). The DPP-IV inhibition assay was carried out in triplicate as outlined previously. 31 The DPP-IV half maximal inhibitory concentration With Y, the DPP-IV IC 50 value;  0 to  5 , the coefficients of the model and ε, the residual of the model. Table 1 . Degree of hydrolysis (DH) and dipeptidyl peptidase IV (DPP-IV) half maximal inhibitory concentration (IC50) of gluten hydrolysates generated within the design of experiments (DOE, H1-H9), H9 digested with pepsin (H9_pepsin), H9_pepsin digested with Corolase PP (H9_CorPP), gluten digested with pepsin (Gluten_pepsin) and Gluten_pepsin digested with Corolase PP (Gluten_CorPP). Mean  SD (n=3). ). The SD of the DPP-IV IC50 value for the H2A, H2B and H2C was 0.13 mg mL Please do not adjust margins
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Liquid chromatography tandem mass spectrometric (LC-MS/MS) analyses of the hydrolysates
Peptide identification in H9 and H9_CorPP was carried out by LC-MS/MS using an Acquity UPLC (Waters) fitted with an Acquity BEH C18, 130 Å column (2.1 mm  50 mm  1.7 µm). The UPLC was coupled to a quadrupole time-of-flight mass spectrometer (Q-TOF, Impact HD™, Bruker Daltonics GmbH, Bremen, Germany) using a 50-600 and 50-2500 m/z acquisition range as described earlier. 33 The MS was fitted with an electrospray ionization (ESI) source used in positive ion mode. Data acquisition was performed with Hystar software (Bruker Daltonics). Samples were resuspended in mobile phase A (0.1% formic acid in MS water) to a final concentration of 0.1 mg mL -1 . A sample volume of 2 µL was injected in the UPLC. Peptide identification was carried with PEAKS Studio (version 7.5, Bioinformatics Solutions Inc, Waterloo, Canada). The false discovery rate (FDR) and the average local confidence (ALC) were set at 1 and 60%, respectively. Previously identified DPP-IV inhibitory peptides for which an IC 50 value was available in the literature as well as peptides displaying features of known DPP-IV inhibitory peptides, i.e., hydrophobic amino acid (Trp (W 1 ), Leu (L 1 ), Ile (I 1 ) or Phe (F 1 )) at the N-terminus and/or a Pro (P 2 )/Ala (A 2 ) at position 2 and/or Pro at the C-terminus (P-term) of the peptide, 11, 19, 34 were searched for within H9 and H9_CorPP.
Statistical analysis
A one-way analysis of variance (ANOVA) at a significance level p < 0.05 was used to study the significance of the coefficient of the MLR (Equation 2) with Matlab. The DH and DPP-IV IC 50 values of the triplicate determination of H2 was studied using an ANOVA which was followed by a Student Newman-Keuls test for multiple means comparison (p < 0.05) using SPSS (version 22, SPSS Inc., Chicago, IL, USA).
Results
DPP-IV inhibitory properties of the gluten hydrolysates
Gluten controls were not able to inhibit DPP-IV (IC 50 > 1.9 mg mL -1
). In contrast, all hydrolysates (H1-H9) generated within the DOE displayed DPP-IV inhibitory properties. Their DPP-IV IC 50 ranged from 0.24  0.02 (H9) to 0.66  0.06 mg mL -1 (H2A and H7, Table 1 ). Hydrolysate generation was reproducible from a DPP-IV inhibition point of view for H2B and H2C (p > 0.05, Table 1 ). Significant differences were seen between H2A and H2B/H2C (p < 0.05). However, all these three hydrolysates had DPP-IV IC 50 values of the same order. These differences may come from the fact that gluten is poorly soluble in water, which may have resulted in some variation in the peptides released during the hydrolysis process. While statistical treatment indicated that hydrolysis temperature had a significant effect on the DPP-IV IC 50 value (p < 0.05, Table 2 ), the MLR model was not statistically significant (p > 0.05, Table 2 ).
Physicochemical properties of the gluten hydrolysates
The protein content of the starting gluten preparation was determined to be 61.71 ± 0.66% (w/w). Gluten was hydrolysed to different extents depending on the hydrolysis conditions employed. The DH of the nine hydrolysates generated within the DOE varied between 31.7  0.9 (H7) and 62.2  3.0% (H6, Table 1 ). The DH of the three hydrolysates (H2A, H2B and H2C) made in the central point conditions were not significantly different (p > 0.05, Table 1 ). Intact gluten contained mostly proteins having a molecular mass > 10 kDa, which accounted for > 95% of the sample (Fig.  1) . Following hydrolysis, proteins were extensively degraded as can be seen in the hydrolysates (H1-H9), which contained < 10% material > 10 kDa (Fig. 1) . Enzymatic digestion of gluten resulted in the generation of low molecular mass components, with the material < 1 kDa representing > 50% of the hydrolysates. H2A, H2B and H2C displayed similar molecular mass distribution profiles (Fig. 1) .
SGID of gluten and H9
Following digestion with pepsin (Gluten_pepsin), the DPP-IV inhibitory properties of gluten were not modified (DPP-IV IC 50 > 1.90 mg mL -1
, Table 1 ). However, further digestion with Corolase PP (Gluten_CorPP) induced a decrease in DPP-IV IC 50 value to 1.45  0.26 mg mL -1 (Table 1 ). The digestion of H9 with pepsin (H9_pepsin) and pepsin and Corolase PP (H9_CorPP) led to an increase in the DPP-IV IC 50 value (0.40  0.03 and 0.33  0.03 mg mL -1 , respectively, Table 1 ).
The molecular mass distribution profile of the SGID samples is illustrated on Fig. 1 . In Gluten_pepsin, proteins (> 10 kDa) were degraded into smaller molecular mass components (< 10 kDa). Proteins were further degraded in Gluten_CorPP. However, both Gluten_pepsin and Gluten_CorPP still contained significant amounts of proteins (> 17% material > 10 kDa). There was a decrease in the proportion of proteins (> 10 kDa) in H9_pepsin. There were no intact proteins remaining in H9_CorPP, which only contained material < 5 kDa (Fig. 1) . Along with differences in molecular mass distribution profiles, H9, H9_pepsin and H9_CorPP displayed different peptide profiles ( Supplementary Fig. S2 ), suggesting that certain sequences within H9 were not stable to digestive enzymes. Coefficients of the parameters having a p < 0.05 are significantly different from 0
Peptides identified within H9 and H9_CorPP
Numerous peptide sequences were identified by LC-MS/MS within H9 and H9_CorPP. Those peptides within both samples for which a DPP-IV IC 50 value had previously been reported in the literature are listed in Table 2 . These consisted of di-and tripeptides. Approximately 95% of the DPP-IV inhibitory peptides reported in Table 2 were common between H9 and H9_CorPP. H9 and H9_CorPP contained relatively potent DPP-IV inhibitory peptides such as, Trp-Leu and Trp-Pro. Val-ProLeu, a potent DPP-IV inhibitor known as Diprotin B, was also found in H9 and H9_CorPP.
Several peptides identified within H9 had the features of DPP-IV inhibitory peptides. Peptides with DPP-IV inhibitory features, which were identified in /-gliadin (accession number P18573), one of the major gluten protein, are listed in Table 3 . While several sequences have been identified for their ability to inhibit DPP-IV in vitro, their DPP-IV IC 50 value has not as yet been evaluated. Two main features were seen among these peptides, i.e., having a Pro in the penultimate or Cterminal positions (~ 80% of the peptides, Table 3 ). Several peptides with an N-terminal Phe or Leu were also present. One peptide with an Ala at the penultimate position was detected while no peptides containing Ile or Trp N-terminal residues were identified. Peptide sequences abbreviated with the one letter amino acid code. Each peptide sequence could be found within several individual wheat proteins. 
Discussion
Several studies have shown that cereal proteins constitute good starting substrates for the generation of bioactive peptides. 43, 44 Gluten, the major protein group in wheat, is a rich source of Pro. Pro residues appear to play a key role in DPP-IV inhibition when they are located in the penultimate or the C-terminal positions of peptides. In addition, in silico studies have indicated that wheat gluten contains numerous DPP-IV inhibitory peptide motifs. 11, 12 Therefore, gluten was evaluated for its ability to serve as a substrate for the enzymatic generation of DPP-IV inhibitory peptides. The DPP-IV inhibitory properties of barley, buckwheat and oat glutenin hydrolysates have been studied. 45, 46 To our knowledge, there is only one previous publication which reported on the DPP-IV inhibitory properties of wheat flour. 16 The highest DPP-IV inhibitory potency was observed with H9 (DPP-IV IC 50 = 0.24  0.02 mg mL -1
, Table 1 ). This value is lower than those generally found with other cereal protein hydrolysates. DPP-IV IC 50 . 38 However, an oat glutenin Alcalase hydrolysate with a DPP-IV IC 50 value (0.13 mg mL -1 ) of the same order as H9 has been described. 45 The DPP-IV inhibitory potency of H9 was ~ 2.5 times higher than that of relatively potent milk 31 and plant (quinoa, 21 hemp, pea, rice and soy) 47 protein hydrolysates evaluated using the same experimental protocol. 
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Peptides sequences abbreviated with the one letter amino acid code. DPP-IV inhibitory peptides are generally relatively short (< 10 amino acids), for review, see:
14
. This is in agreement with the fact that hydrolysates displaying the largest proportion of material < 1 kDa (e.g., H3, H5, H6 and H9) were also generally the most potent DPP-IV inhibitory hydrolysates (Table 1) , for H9 and H9_CorPP, respectively, Table 1 ). The DPP-IV IC 50 value of Gluten_CorPP (1.45  0.26 mg mL -1 , Table 1) was higher than that of the SGID of wheat flour (0.8 mg mL -1 ) 16 but of the same order as that of the SGID of barley, buckwheat or oat flour (0.99-3.91 mg mL -1 ) 45 . The higher DPP-IV inhibitory potency of H9_CorPP compared to Gluten_CorPP suggests that it may be beneficial to prehydrolyse gluten prior to ingestion. Several known DPP-IV inhibitory peptides were identified within H9 and H9_CorPP (Table 2 and 3) , most of which were short ( 3 amino acids). Three relatively potent peptides, ValPro-Leu, Trp-Leu and Trp-Pro, having DPP-IV IC 50 values < 50 µM, 40, 41 were found both in H9 and H9_CorPP (Table 2 ). While these peptides may, in part, be responsible for the DPP-IV inhibitory potency of the hydrolysates, other peptides may also play a role in the overall bioactivity. Peptides with a penultimate Pro have been shown to behave as substrate-type DPP-IV inhibitors. 17, 18 In addition, the presence of Pro at the C-
terminal position also appears to be a good predictor for DPP-IV inhibition activity of peptides. 19, 20 Interestingly, a large proportion (~ 80 %) of the peptides originating from /-gliadin, which were identified within H9, contained either a penultimate or C-terminal Pro (Table 3) .
Debitrase HYW20, does not appear to have been used for the generation of DPP-IV inhibitory food protein hydrolysates, for review, see: Lacroix and Li-Chan. 14 Debitrase HYW20 is an enzyme preparation derived from Aspergillus niger, with an unknown cleavage specificity. It has been reported to contain both endo-and exoprotease activities, 22 which may explain the relatively high DH values observed in the hydrolysates (Table  1) . Similar DH values up to 43 48 or 64% 49 have been reported for wheat gluten hydrolysates obtained with Flavourzyme and Alcalase, respectively, which are two enzyme preparations also having broad cleavage specificity. The presence of these Pro-containing peptides possessing DPP-IV inhibitory features within H9 is partly explained by the particularly high Pro content of gluten. In addition, it is likely that the enzyme activities within Debitrase HYW20 also played a role in DPP-IV inhibitory peptide release. The relatively minor reduction of the DPP-IV IC 50 value of H9 following SGID (H9_CorPP) may arise from the fact that Pro-containing peptides have been reported to be relatively stable to digestive enzymes. 50 Future work may include bioassay-driven fractionation of H9, confirmatory studies with synthetic peptides and quantification of DPP-IV inhibitory peptides. The study of their technofunctional and additional other bioactive properties of the wheat gluten hydrolysates is also of interest. Wheat gluten hydrolysates have been shown to possess a range of technofunctionalities. 49, 51 Furthermore, in the context of coeliac disease, the degradation of gluten epitopes through Please do not adjust margins
Please do not adjust margins the enzymatic hydrolysis used herein is also worthy of further investigation.
48,52,53
Conclusions
Gluten can be used as a protein substrate for the enzymatic generation of DPP-IV inhibitory hydrolysates. H9, a relatively potent DPP-IV inhibitory hydrolysate was produced on incubation (60C for 24 h) of gluten with Debitrase HYW20 at an E:S of 1.5%. This hydrolysate contained short (di-and tri-) peptides previously identified as DPP-IV inhibitors. In addition, several peptides possessing DPP-IV inhibitory features, mostly comprising of Pro residues at the penultimate and C-terminal positions, were identified within H9. These may play a role in the overall DPP-IV inhibitory properties of H9. Interestingly, the DPP-IV inhibition activity of H9 was minimally reduced following SGID. In addition, the higher DPP-IV inhibitory potency of H9_CorPP compared to that of Gluten_CorPP, suggests the possibility of a more efficient release of DPP-IV inhibitory peptides on prehydrolysis of gluten prior to ingestion. In vivo evaluation of the gluten hydrolysates is required in order to study their antidiabetic potential.
